Sirolimus (Greenstone LLC)


Welcome to the PulseAid listing for the Sirolimus drug offered from Greenstone LLC. This Decreased Immunologic Activity [PE],mTOR Inhibitor Immunosuppressant [EPC],mTOR Inhibitors [MoA],Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Greenstone LLC
NON-PROPRIETARY NAME: SIROLIMUS
SUBSTANCE NAME: SIROLIMUS
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Immunologic Activity [PE],mTOR Inhibitor Immunosuppressant [EPC],mTOR Inhibitors [MoA],Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, SUGAR COATED
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2014-01-07
END MARKETING DATE: 0000-00-00


Sirolimus HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSirolimus from Greenstone LLC
LABELER NAME: Greenstone LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 0.5(mg/1)
START MARKETING DATE: 2014-01-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 59762-1001_62fa522f-54f1-40e7-af5c-2408ce9e7176
PRODUCT NDC: 59762-1001
APPLICATION NUMBER: NDA021110

Other SIROLIMUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Health PackagingSirolimus
Cadila Healthcare Limitedsirolimus
Cardinal HealthRapamune
Dr. Reddy’s Laboratories LimitedSirolimus
Greenstone LLCSirolimus
Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.Rapamune
Zydus Pharmaceuticals (USA) Inc.sirolimus